Common Colds Patents of George A. Eby
coldcure.com
All of these patents are available for assignment as a single package.
Cure for Common Cold U.S. Patent 5,409,905
PTO Full text of U.S. Patent Number 5,409,905 issued Apr. 25, 1995 (Cure for Common Cold)
European Patent Application will issue soon!!!! (Flavor Stable Zinc Acetate Compositions for Oral Absorption with common cold treatment claim) available to be nationalized for Austria, Belgium, Denmark, France, Germany, Great Britain, Italy, Netherlands, Sweden, Switzerland/Liechtenstein.
Flavor Stable Zinc Acetate Compositions for Oral Absorption Canadian patent number 2,099,670 granted March 30, 1999.
U. S. Patent Number 5,286,748 issued Feb. 15, 1994 (General Method of Shortening the Duration of Common Colds by Application of Medicaments to Tissues of Oral Cavity)
U. S. Patent Number 5,095,035 issued Mar. 10, 1992 (Flavor Stable Zinc Acetate Compositions for Oral Absorption)
U. S. Patent Number 5,002,970 issued Mar. 26, 1991 (Flavor Masked Ionizable Zinc Compositions for Oral Absorption)
U. S. Patent Number 4,956,385 issued Sep. 11, 1990 (Method for Reducing the Duration of the Common Cold [improved])
The above U.S patents and Canadian patent are non-exclusively licensed and commercialized and can be assigned.
U. S. Patent Number Re. 33,465 issued Nov. 27, 1990 (Method of Reducing the Duration of Common Colds - a reissue of U.S. Patent Number 4,503,070) This patent has expired.
This is a public health warning to innovators trying to capitalize on these discoveries without tresspassing on these patents. Seeing and understanding what to expect from other zinc lozenges is mandatory viewing. Did you know that zinc citrate lozenges or any zinc lozenges containing citric acid can make colds worse? Even eating an orange while using the above patented lozenges can worsen colds. Citric acid and zinc are toxic when allowed to be absorbed into the oral tissues, but not when swallowed as a tablet and dissolution occurs in the stomach. |
